banner2

Getting started
24-Dichloro-3-Pyridinecarboxylic Acid CAS 262423-77-8

24-Dichloro-3-Pyridinecarboxylic Acid CAS 262423-77-8 - Manufacturers, Suppliers, Factory from China

24-Dichloro-3-Pyridinecarboxylic Acid CAS 262423-77-8, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

2,4-Dichloronicotinic Acid CAS 262423-77-8 Purity 98.0 (GC) (T) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 2,4-Dichloronicotinic Acid CAS 262423-77-8 Purity >98.0% (GC) (T)
Read More

DL-2,3-Diaminopropionic Acid Hydrochloride CAS 54897-59-5 Assay 98.5-101.5% (Titration) Purity ≥99.0% (HPLC)

2,3-Diaminopropionic Acid CAS 515-94-6 Assay ≥98.0% (Titration)

DL-2,3-Diaminopropionic Acid Hydrobromide CAS 18635-45-5 Assay ≥98.0% (Titration)

DL-2-Aminobutyric Acid CAS 2835-81-6 Assay ≥99.0% (Titration)

DL-Homocysteic Acid CAS 504-33-6 Assay ≥98.0% (TLC)

Z-D-Glutamic Acid (Z-D-Glu-OH) CAS 63648-73-7 Assay ≥98.0% (HPLC)

banner1

Top Selling Products

Related Blog
Reviews

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...

2022.12.06 22:19:20
2022.10.02 08:18:13
2022.07.19 09:02:03
2022.03.11 09:35:04
2022.01.10 22:38:59
2021.12.12 08:31:25

related search